Stay updated on ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision label also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:17:50.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:22:37.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The study page for NCT02523469 now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previously available trial content and documents.
    Difference
    20%
    Check dated 2026-09-23T00:13:01.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous v3.6.6. This appears to be a minor update to the page's backend or presentation without altering the study content or user-facing data.
    Difference
    0.1%
    Check dated 2026-09-15T23:25:15.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The displayed Revision tag has been updated to v3.6.6, replacing the previous v3.6.5, indicating a software revision rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-09-01T18:08:03.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.4 to v3.6.5, signaling a newer version of the page. The update does not alter the study content, eligibility criteria, or results on the page.
    Difference
    0.0%
    Check dated 2026-08-11T08:29:46.000Z thumbnail image

Stay in the know with updates to ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.